Related Experiment Video
Updated: Aug 9, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
New therapeutic targets in cancer: the epigenetic connection
Michel Herranz1, Manel Esteller
1Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Abstract:
Cancer is an epigenetic disease, a combination of DNA modifications, chromatin organization and variations in its associated proteins, configure a new entity that regulates gene function throughout methylation, acetylation and chromatin remodelling. Irregular de novo DNA methylation, mainly promoter hypermethylation, histone deacetylation or methylation are important means for the transcriptional repression of cancer-associated genes. Reverse these epigenetic processes restoring normal expression of malignancy- preventing-genes has consequently become a new therapeutic target in cancer treatment. Aberrant patterns of epigenetic modifications will be, in a near future, crucial parameters in cancer diagnosis, prognosis and therapy.
Insights
Cancer is an epigenetic disease driven by DNA modifications and chromatin changes. Reversing these epigenetic alterations offers a promising new therapeutic strategy for cancer treatment and diagnosis.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer is fundamentally an epigenetic disease.
- Epigenetic dysregulation involves DNA methylation, histone modifications, and chromatin remodeling.
- These alterations impact gene expression, promoting cancer development.
Purpose of the Study:
- To highlight the role of epigenetic modifications in cancer.
- To explore the therapeutic potential of reversing epigenetic changes.
- To emphasize the future diagnostic and prognostic value of epigenetic markers.
Main Methods:
- Analysis of DNA methylation patterns.
- Assessment of histone acetylation and methylation.
- Chromatin remodeling studies.
Main Results:
- Aberrant DNA methylation, particularly promoter hypermethylation, represses cancer-associated genes.
- Histone deacetylation and methylation also contribute to transcriptional repression.
- Reversing these epigenetic marks can restore the expression of tumor-suppressor genes.
Conclusions:
- Epigenetic modifications are key drivers of cancer.
- Targeting epigenetic processes represents a novel therapeutic avenue.
- Epigenetic patterns hold significant potential for cancer diagnosis, prognosis, and personalized therapy.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle